OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes

HTML

Year: 2017
Type: article
Source: Postgraduate Medicine
DOI: 10.1080/00325481.2017.1342509
Authors: Robert S. Busch, Michael P. Kane
Institutions: Albany Medical Center Hospital, Albany College of Pharmacy and Health Sciences
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, SGLT2 inhibitors, GLP-1 receptor agonists, combination therapy, exenatide, dapagliflozin, liraglutide, semaglutide, empagliflozin, glycemic control, weight loss, cardiovascular risk, HbA1c, systolic blood pressure, comorbidities
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2725053346
FWCI: 5.829
Cites: 83
Cited by: 63
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security